Dapsone Topical and Nitroglycerin Interaction

Understanding the Dapsone Topical and Nitroglycerin Interaction

FDA-approved prescribing information for these two drugs flags their combination as a moderate-severity interaction. Dapsone Topical belongs to the Topical Anti-Inflammatory class and Nitroglycerin belongs to the Nitrate Vasodilator class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: These drugs can both cause a buildup of a specific type of hemoglobin that does not carry oxygen effectively. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Dapsone Topical has 10 total documented interactions on file in this dataset, and Nitroglycerin has 8. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Use this combination carefully and seek medical help immediately if you notice your skin, lips, or fingernails turning blue. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Dapsone Topical or Nitroglycerin based on a web page, speak with your prescriber or pharmacist before making any change.